The Core Model: A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care develops the innovative core model, an organizational research and design paradigm and economic theory proposing a collaborative approach to resolving global health issues and improve productivity of drug development. The Core Model proposes that scientific collaboration in society does not occur in an "unstructured" manner, but actually takes place within a highly structured order through which knowledge is transferred, integrated, and finally translated into commercial products for the benefit of society. The way in which this is accomplished is via such avenues as an exchange of information, knowledge, experimental results, and personal connections among collaborating parties. This trading of assets among collaborators is the driving force of innovation and, if done correctly, could save time, labor, and economic resources when developing a new drug. The understanding of this model and its application, by the private and public sectors, could help us solve the global pharmaceutical industry´s productivity problems and address important global health care and economic issues, such as having affordable access to high-quality innovative drugs. This book is useful to researchers, advanced students, regulators and management in pharmaceutical industries, as well as healthcare professionals, those working in health economics, and those interested in scientific innovation processes.
- Explores current state of the pharmaceutical industry and the global health care sector
- Includes insights from world-leading figures in the pharmaceutical industry, health care sector, federal funding agencies, regulatory bodies, investment sector, entrepreneurship, intellectual property law, philanthropic organizations, and advocacy groups
- Develops in-depth, original concepts, which have important implications in the understanding of and search for potential solutions to the world´s health care crisis
Researchers, advanced students and management in the pharmaceutical industry and disease foundations. Healthcare professionals, FDA staff, business graduates, anyone interested in medical technology development, and scientific innovation
- Introduction: The Core Model
2. The "Core"
3. "The Bridge"
4. "The Periphery"
5. The Core Model and Intellectual Property and Financial Interests
6. The Core Model and The Pharmaceutical Industry Productivity Crisis
7. The Core Model, Innovation, Economic Growth and Development and Policy-Making
8. The Core Model and Global Health Care
9. Conclusion The Core Model: A Novel Economic Theory
- No. of pages:
- © Academic Press 2019
- 1st October 2018
- Academic Press
- Paperback ISBN:
Ibis Sánchez-Serrano is an independent, world-leading figure in health care. He is the author of the book “The World´s Health Care Crisis: From the Laboratory Bench to the Patient´s Bedside” (Elsevier, 2011; Highly Recommended" --Choice); author of the seminal article on translational research, where the Core Model appeared for the first time. He is a member of the Editorial Board of the Journal Gender & the Genome, has received many international recognitions for his work on global health care, including a “Fulbright Recognition Award”, a nomination to the world-class “Prince of Asturias” Award, and important world-class TV and media coverage, including CNN, C-SPAN, UNIVISION, EFE Agency, Deutsche Presse Agentur, etc. He is the President of “The Core Model Corporation”, a health-care and pharmaceutical start-up. He is a frequent speaker on global health care and pharmaceutical development
President and Founder, The Core Model Corporation, S.A. (C.M.C.), Panama City, Panama